Trump administration moves forward with certain drug reclassifications
Quick Insights
The Bottom Line
President Trump signed an executive order to facilitate research into psychedelics for mental illnesses.
How This Affects You
This action could lead to new medical treatments for mental health conditions, potentially offering new therapeutic options for Americans.
AI Summary
President Trump signed an executive order on Saturday to facilitate more research into psychedelics as treatments for certain mental illnesses. This action by the Trump administration follows his December 2025 move to reclassify marijuana as a less dangerous drug. The executive order paves the way for potential medical advancements in mental health care. Josh Kesselman, founder of RAW rolling papers and publisher of High Times Magazine, is expected to provide further commentary on these developments.
What's Being Done
President Trump signed an executive order.
Source Coverage Map
2 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
1 sourceMultiple outlets have reported on this story. Compare perspectives from different sources.
Psychedelic drug makers rally as Trump orders FDA to expedite reviews - Yahoo Finance
This article is part of a story we're tracking:
Trump Administration Actions and Policies
The Trump administration is taking various actions, including restarting the Global Entry program, pushing for college sports legislation, and facing scrutiny over its handling of the Iran conflict and its impact on the State Department.
Trump Administration's Domestic Policies and Political Maneuvers
The Trump administration is implementing and proposing various domestic policies, including restoring gun rights for felons, restarting Global Entry, and facing scrutiny over DHS policies. These actions are occurring amidst political maneuvering for upcoming elections.
Trump Administration's Policies and Political Landscape
The Trump administration continues to face scrutiny over its policies, including efforts to support coal plants and a controversial settlement in a predatory lending case. Simultaneously, discussions about invoking the 25th Amendment and limiting the President's powers are gaining traction among Democrats, while some former allies express criticism.
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
HealthFDA Commissioner Marty Makary breaks down Trump's executive order on psychedelics
President Trump has signed an executive order to expand research into psychedelic drugs for mental health treatment. Dr. Marty Makary, commissioner of the Food and Drug Administration, joins CBS News to discuss.
PoliticsWhat to Know About Trump’s New Executive Order on Psychedelic Drugs
The order calls for the FDA to give expedited consideration to certain psychedelic drugs.
PoliticsWatch live: Trump signs executive order from White House
President Trump will sign an executive order centered on medical research from the White House on Saturday morning. The event comes a day after Trump gave remarks in Phoenix focused on his agenda and courting voters ahead of the midterms, garnering the president a standing ovation. It also comes after the administration unveiled its fiscal…
PoliticsTrump signs order to speed review of psychedelics, including the controversial drug ibogaine - AP News
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNUzlaeEZMcTdjcFV0aGpYZi11X2pLUTgzamxyX2NwMWFraldDYmNjdGZkQmVlbnYyNjVwOUZ1LXdhbzhzTUhvclFmVDAzZWEwd3RfTHZ1YzZmQTZ1M1RZLXlOcDlwV1lfQzhfNWY2S3NfQVd2NFZYRnhWRW5XMm93eVRqbnRSYVFQX2VYa2xpd3h1eUUzS2ZJVUVQMjUtRllYWHgwSEpMMDBrNWFEajBJMEN3?oc=5" target="_blank">Trump signs order to speed review of psychedelics, including the controversial drug ibogaine</a> <font color="#6f6f6f">AP News</font>
EnvironmentFederal judge blocks Trump administration restrictions on wind and solar projects
<p>The injunction pauses policy giving senior Trump official direct sign-off on federal clean energy projects</p><p>A federal judge in Massachusetts on Tuesday struck down several <a href="https://www.theguardian.com/us-news/trump-administration">Trump administration</a> actions slowing down development of clean energy, including a requirement that all solar and wind energy projects on federal lands and waters be personally approved by the interior secretary, Doug Burgum.</p><p>Denise J Casper, chief judge of the US district court for Massachusetts, ruled that a coalition of plaintiffs representing wind and solar developers were likely to succeed on the merits of their claims that the administration’s actions violate federal statute and will cause irreparable harm if the court did not intervene.</p> <a href="https://www.theguardian.com/us-news/2026/apr/22/trump-wind-solar-clean-energy-order">Continue reading...</a>
PoliticsScoop: Trump set to reclassify marijuana soon
<p>The <a href="https://www.axios.com/politics-policy/donald-trump" target="_blank">Trump</a> administration is expected to move to <a href="https://www.axios.com/2025/12/18/trump-reclassify-marijuana-weed-schedule-drugs" target="_blank">reclassify</a> marijuana as soon as Wednesday, per an administration official familiar with the matter.</p><p><strong>Why it matters: </strong>The move would make it easier to study medicinal applications of marijuana and could shore up support from <a href="https://www.axios.com/2026/04/20/trump-woos-rogan-after-split" target="_blank">influencers</a> who support the research.</p><hr><ul><li>The move follows an executive order from the president last year to reclassify marijuana as a Schedule III drug, which is a years-long process. </li></ul><p><strong>How it works: </strong><a href="https://www.axios.com/2025/12/12/trump-marijuana-federal-restrictions-reclassify" target="_blank">Reclassifying</a> marijuana eases U.S. Drug Enforcement Administratio...
RFK Jr. defends vaccine guidance changes and health spending cuts
Health Secretary Robert F. Kennedy Jr. was back testifying on Capitol Hill, giving members of Congress a chance to press him on some of the biggest changes he's making on spending cuts, vaccines and other public health issues. Lisa Desjardins reports.
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump
One in three Americans forced to make financial sacrifices for health coverage
Trump-branded data center project CEO departs
US Live Nation and Ticketmaster verdict triggers calls for Australian investigation into ticketing rules
Labor Secretary Lori Chavez-DeRemer is leaving Trump's Cabinet after abuse of power allegations - AP News
